or Try an Advanced Search...

    ETF Components for SYNB - Putnam BioRevolution ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    TMO C -0.04 6.91
    DHR C -0.24 6.31
    BIO B 1.46 5.26
    NVDA C 1.58 5.16
    GOOGL B -0.68 4.61
    REGN D -0.63 4.33
    CTVA A 1.12 4.30
    ABBV A -0.07 4.29
    LLY D 0.75 4.14

    Represented by ETF Holdings

    Keywords: S&P 500 Biotechnology Nasdaq 100 Analytical Instruments Asthma Atopic Dermatitis Autoimmune Disease Bio Rad Laboratories Bone Cholesterol Computing Depressive Disorder IBD 50 Lab Testing Mobile Devices Ortho Clinical Diagnostics Radiometer Smartphones Test Systems Adalimumab
    Industries: Diagnostics & Research Drug Manufacturers - Major Agricultural Inputs Biotechnology Internet Content & Information Semiconductors

    Recent News for Putnam BioRevolution ETF & its Holdings

    Date Stock Title
    Oct 3 NVDA This Incredibly Cheap Tech Stock Has Crushed Nvidia in the Past 3 Months, and It Is Still a Solid Buy
    Oct 3 NVDA Trending tickers: Nvidia, Microsoft, Tesla, Levi's and Tesco
    Oct 3 NVDA Beyond Nvidia: 2 Spectacular Growth Stocks Billionaires Can't Stop Buying
    Oct 3 NVDA Should You Buy Nvidia Before Oct. 7?
    Oct 3 NVDA Wall Street's Newest Artificial Intelligence (AI) Stock Split Has Arrived -- and It's Following in the Footsteps of Nvidia and Broadcom
    Oct 3 NVDA Nvidia Stock Rises. OpenAI Deal Will Have This Impact.
    Oct 3 NVDA Could Nvidia Stock Soar If Donald Trump Wins in November?
    Oct 3 NVDA Appaloosa Management’s David Tepper Urges Caution on NVIDIA Corporation (NVDA) Amid Concerns Over Long-Term AI Growth Prospects
    Oct 3 NVDA Is It Too Late to Buy Nvidia Stock? Wall Street's Answer May Surprise Investors
    Oct 3 NVDA Biden Signs Law To Exempt Certain US Chipmaking Facilities From Federal Environmental Reviews Under CHIPS Act
    Oct 3 GOOGL Better Quality Or Higher Loyalty? Apple's iPhone Users Retain Their Devices Longer Than Those Buying Google's Pixel And Samsung's Galaxy Smartphones
    Oct 3 NVDA NVIDIA Corporation (NVDA) Maintains Strong Pricing for Hopper Line Ahead of Blackwell Launch, with Stable Aftermarket Prices for H100, Says Susquehanna Analyst
    Oct 3 NVDA Nvidia CEO Jensen Huang Says Demand For Next-Gen Blackwell GPU Platform Insane: 'Everyone Wants To Have The Most, And Everyone Wants To Be First'
    Oct 3 NVDA Nvidia, Palantir, Clover Health, Joby Aviation, Tesla: Why These 5 Stocks Are On Investors' Radars Today
    Oct 3 NVDA Jensen Huang On Transformative Partnership With Accenture: AI As 'Digital Employees' Will Revolutionize Productivity
    Oct 2 GOOGL I’m Listening to Podcasts Created by Google’s AI. It Could Be a ChatGPT Moment.
    Oct 2 NVDA OpenAI Nearly Doubles Valuation to $157 Billion in Funding Round
    Oct 2 NVDA Demand for NVIDIA's Blackwell is 'insane' - Jensen Huang
    Oct 2 NVDA How Much Will Nvidia Pay Out in Dividends This Year?
    Oct 2 NVDA Nvidia (NVDA) Laps the Stock Market: Here's Why
    Putnam BioRevolution ETF is an exchange traded fund launched and managed by Putnam Investment Management, LLC. The fund is co-managed by Putnam Investments Limited. It invests in the public equity markets. It invests in stocks of companies operating across healthcare, pharmaceuticals, biotechnology, life sciences and biology revolution sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. Putnam BioRevolution ETF is domiciled in the United States.
    Exchange Traded Funds Biotechnology SPDR Betashares Pharmaceutical
    Back to the Main SYNB Page...